ARS-Based, Interactive Session Focused on Patient with T2D Who is On an Oral Agent Plus Basal Insulin and Has Suboptimal Control of Total HA1c Level and Who Has Evidence of PPG

ARS-Based, Interactive Session Focused on Patient with T2D Who is On an Oral Agent Plus Basal Insulin and Has Suboptimal Control of Total HA1c Level and Who Has Evidence of PPG


Published

November 21, 2018

Created by

CMEducation Resources symposium

Related Presenters